TB-500 10mg Vial

TB-500 is a synthetic peptide derived from thymosin beta-4. This naturally occurring peptide is found in human cells and plays a role in cellular processes linked to tissue repair and regeneration.

TB-500 is studied in laboratory settings for its role in tissue regeneration, wound healing, and injury recovery. Research has focused on how it interacts with actin, a structural protein involved in cell movement and repair processes.

At Futureproof Peptides, we sell TB-500 10mg vials for research use only.

 

Human Studies & Research Focus

Research on thymosin beta-4, the parent compound of TB-500, has examined tissue repair, wound healing, and recovery in damaged tissues. Studies have also looked at how cells migrate and respond during injury recovery.

Research has also explored:

• Tissue regeneration
• Wound healing response
• Reduces inflammation
• Anti inflammatory signalling
• Extracellular matrix activity

 

Some studies suggest TB-500 supports faster recovery in damaged tissues through increased cell migration and blood vessel formation. These findings are limited to controlled research environments.

 

Biological Relevance

TB-500 is linked to thymosin beta-4, a peptide involved in actin regulation. This process is important for cell movement, tissue repair, and structural organisation. It allows cells to migrate into damaged tissues and support wound healing processes.

Research has examined:

• Tissue repair and regeneration
• Wound healing and injury recovery
• Reduces inflammation in cellular models
• Hair growth related activity
• Recovery in muscle and connective tissue

 

TB-500 has also been studied for its role in angiogenesis and cellular signalling linked to repair processes.

 

Areas of Ongoing Research

Current laboratory research on TB-500 includes:

• Tissue regeneration models
• Wound healing and damaged tissues
• Injury recovery and muscle repair
• Anti inflammatory response
• Long term recovery mechanisms

 

These areas remain under investigation and are not established for clinical use.

 

Administration Context In Research

TB-500 is typically supplied as a lyophilised powder and requires reconstitution using bacteriostatic water prior to research use (source).

Some experimental models reference injection site observation following administration. These methods are limited to controlled laboratory environments.

No guidance is provided for use outside of research settings.

 

Side Effects and Limitations In Research

Research into TB-500 and thymosin beta-4 is still ongoing. Some studies note limited human data and unknown long term effects. Reported side effects in research settings are generally mild, though data remains limited.

 

Format And Handling

Our TB-500 10mg Vial is supplied as a lyophilised peptide powder. This format supports stability during storage and transport.

Reconstitution is required prior to use, typically using bacteriostatic water. Proper handling includes temperature control and avoiding repeated freeze and thaw cycles.

Disclaimer: This product is sold strictly for research purposes only. It is not intended for medical, cosmetic, or therapeutic use. Not for human consumption.